Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Women with PCOS are more likely to have gum disease.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Apple polyphenol, especially oligomeric procyanidins, can reduce fat absorption and lower blood fat levels.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

High kallistatin levels in diabetics worsen wound healing by blocking important cell signals.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Melatonin may help treat PCOS symptoms in rats.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

People with Parkinson's disease have higher levels of cortisone in their hair, which may indicate chronic stress hormone dysfunction.

Women with early onset androgenetic alopecia have worse lipid profiles.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Premature hair greying may indicate a higher risk of metabolic problems.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Women with PCOS have higher levels of thyroid autoantibodies.

Lower adiponectin levels are linked to higher insulin resistance in women with PCOS.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Metformin helps reduce PCOS-related infertility by improving insulin sensitivity and inducing ovulation.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.